login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
TOURMALINE BIO INC (TRML) Stock News
USA
- NASDAQ:TRML -
US89157D1054
-
Common Stock
47.65
USD
+0.04 (+0.08%)
Last: 9/15/2025, 7:15:50 PM
47.65
USD
0 (0%)
After Hours:
9/15/2025, 7:15:50 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TRML Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Chartmill
- Mentions:
VNCE
TOP
WLDS
MGIH
...
Unusual volume stocks in Thursday's session
6 days ago - By: Chartmill
- Mentions:
NVS
FCEL
MSFT
AAPL
...
Wall Street Cheers Nebius-Microsoft Megadeal While Apple Misses the Mark
13 hours ago - By: Benzinga
- Mentions:
ARRY
CVI
NMFC
RH
This New Mountain Finance Analyst Turns Bearish; Here Are Top 3 Downgrades For Monday
4 days ago - By: Kahn Swick & Foti, LLC
TOURMALINE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Tourmaline Bio, Inc. - TRML
5 days ago - By: Zacks Investment Research
- Mentions:
NVS
NVO
NVS to Acquire TRML, Add Phase III Cardiovascular Drug to Pipeline
6 days ago - By: Chartmill
- Mentions:
NBY
UUU
MOVE
MEIP
...
Let's take a look at the stocks that are in motion in today's session.
6 days ago - By: Benzinga
- Mentions:
KFY
PACS
SAIL
CNM
...
Dow Surges Over 100 Points; Korn Ferry Earnings Top Views
6 days ago - By: Halper Sadeh LLC
- Mentions:
WOW
BTBD
WKHS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TRML, WOW, BTBD, WKHS on Behalf of Shareholders
6 days ago - By: Brodsky & Smith LLC
- Mentions:
BTBD
WOW
WKHS
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Tourmaline Bio, Inc. (Nasdaq - TRML), BT Brands, Inc. (Nasdaq - BTBD), WideOpenWest, Inc. (NYSE - WOW), Workhorse Group Inc. (Nasdaq - WKHS)
6 days ago - By: Investor's Business Daily
- Mentions:
NVS
NVO
Novartis Snaps Up Cardio-Focused Tourmaline Bio For $1.4 Billion
6 days ago - By: Investor's Business Daily
- Mentions:
NVS
NVO
Why Novartis' $1.4 Billion Takeover Of Tourmaline Bio Just 'Makes Sense'
7 days ago - By: Stocktwits
- Mentions:
NVS
Tourmaline Bio Stock Just Rocketed 58% Pre-Market – Here’s What Happened
7 days ago - By: Halper Sadeh LLC
TRML Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Tourmaline Bio, Inc. Is Fair to Shareholders
7 days ago - By: The Ademi Firm
Shareholder Alert: The Ademi Firm investigates whether Tourmaline Bio, Inc. is obtaining a Fair Price for its Public Shareholders
7 days ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
7 days ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Enters into Agreement to be Acquired by Novartis AG
15 days ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress
15 days ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Presents Data from the Ongoing Phase 2 TRANQUILITY Trial at the 2025 European Society of Cardiology Congress
a month ago - By: Zacks Investment Research
Wall Street Analysts Predict a 151% Upside in Tourmaline Bio, Inc. (TRML): Here's What You Should Know
a month ago - By: The Motley Fool
Tourmaline Bio Reports Loss as R&D Rises
a month ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
a month ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Reports Second Quarter 2025 Financial Results and Recent Business Highlights
4 months ago - By: Yahoo Finance
- Mentions:
HOOD
BLFS
V
APP
...
Robinhood Expands Desktop Trading Platform to UK
4 months ago - By: Yahoo Finance
- Mentions:
ROIV
UBS
WLK
IMVT
...
H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock
4 months ago - By: Yahoo Finance
- Mentions:
ROIV
IMVT
DHI
CMG
H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results
4 months ago - By: Yahoo Finance
BMO Sees Overreaction, Maintains Rating and Price Target on Tourmaline Bio (TRML)
4 months ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Announces Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High-Sensitivity C-reactive Protein and Chronic Kidney Disease
4 months ago - By: Tourmaline Bio, Inc.
Tourmaline Bio Announces Positive Topline Results from the Ongoing Phase 2 TRANQUILITY Trial Evaluating Pacibekitug in Patients with Elevated High-Sensitivity C-reactive Protein and Chronic Kidney Disease
Please enable JavaScript to continue using this application.